BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 24486718)

  • 1. Curcumin inhibits proliferation of breast cancer cells through Nrf2-mediated down-regulation of Fen1 expression.
    Chen B; Zhang Y; Wang Y; Rao J; Jiang X; Xu Z
    J Steroid Biochem Mol Biol; 2014 Sep; 143():11-8. PubMed ID: 24486718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Letrozole improves the sensitivity of breast cancer cells overexpressing aromatase to cisplatin via down-regulation of FEN1.
    Wang Y; Li S; Zhu L; Zou J; Jiang X; Chen M; Chen B
    Clin Transl Oncol; 2019 Aug; 21(8):1026-1033. PubMed ID: 30712236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin down-regulates visfatin expression and inhibits breast cancer cell invasion.
    Kim SR; Park HJ; Bae YH; Ahn SC; Wee HJ; Yun I; Jang HO; Bae MK; Bae SK
    Endocrinology; 2012 Feb; 153(2):554-63. PubMed ID: 22186408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug resistance associates with activation of Nrf2 in MCF-7/DOX cells, and wogonin reverses it by down-regulating Nrf2-mediated cellular defense response.
    Zhong Y; Zhang F; Sun Z; Zhou W; Li ZY; You QD; Guo QL; Hu R
    Mol Carcinog; 2013 Oct; 52(10):824-34. PubMed ID: 22593043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. YY1 suppresses FEN1 over-expression and drug resistance in breast cancer.
    Wang J; Zhou L; Li Z; Zhang T; Liu W; Liu Z; Yuan YC; Su F; Xu L; Wang Y; Zhou X; Xu H; Hua Y; Wang YJ; Zheng L; Teng YE; Shen B
    BMC Cancer; 2015 Feb; 15():50. PubMed ID: 25885449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nrf2 knockdown by shRNA inhibits tumor growth and increases efficacy of chemotherapy in cervical cancer.
    Ma X; Zhang J; Liu S; Huang Y; Chen B; Wang D
    Cancer Chemother Pharmacol; 2012 Feb; 69(2):485-94. PubMed ID: 21842204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of aldose reductase expression mediated by phosphatidylinositol 3-kinase/Akt and Nrf2 is involved in the protective effect of curcumin against oxidative damage.
    Kang ES; Woo IS; Kim HJ; Eun SY; Paek KS; Kim HJ; Chang KC; Lee JH; Lee HT; Kim JH; Nishinaka T; Yabe-Nishimura C; Seo HG
    Free Radic Biol Med; 2007 Aug; 43(4):535-45. PubMed ID: 17640564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting DNA Flap Endonuclease 1 to Impede Breast Cancer Progression.
    He L; Zhang Y; Sun H; Jiang F; Yang H; Wu H; Zhou T; Hu S; Kathera CS; Wang X; Chen H; Li H; Shen B; Zhu Y; Guo Z
    EBioMedicine; 2016 Dec; 14():32-43. PubMed ID: 27852524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propofol induces proliferation partially via downregulation of p53 protein and promotes migration via activation of the Nrf2 pathway in human breast cancer cell line MDA-MB-231.
    Meng C; Song L; Wang J; Li D; Liu Y; Cui X
    Oncol Rep; 2017 Feb; 37(2):841-848. PubMed ID: 28035403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetics Reactivation of Nrf2 in Prostate TRAMP C1 Cells by Curcumin Analogue FN1.
    Li W; Pung D; Su ZY; Guo Y; Zhang C; Yang AY; Zheng X; Du ZY; Zhang K; Kong AN
    Chem Res Toxicol; 2016 Apr; 29(4):694-703. PubMed ID: 26991801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wilms' tumour gene 1 (WT1) as a target in curcumin treatment of pancreatic cancer cells.
    Glienke W; Maute L; Wicht J; Bergmann L
    Eur J Cancer; 2009 Mar; 45(5):874-80. PubMed ID: 19196508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FEN1 mediates miR-200a methylation and promotes breast cancer cell growth
    Zeng X; Qu X; Zhao C; Xu L; Hou K; Liu Y; Zhang N; Feng J; Shi S; Zhang L; Xiao J; Guo Z; Teng Y; Che X
    FASEB J; 2019 Oct; 33(10):10717-10730. PubMed ID: 31266372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flap endonuclease 1 is a promising candidate biomarker in gastric cancer and is involved in cell proliferation and apoptosis.
    Wang K; Xie C; Chen D
    Int J Mol Med; 2014 May; 33(5):1268-74. PubMed ID: 24590400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-140 impedes DNA repair by targeting FEN1 and enhances chemotherapeutic response in breast cancer.
    Lu X; Liu R; Wang M; Kumar AK; Pan F; He L; Hu Z; Guo Z
    Oncogene; 2020 Jan; 39(1):234-247. PubMed ID: 31471584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice.
    Aggarwal BB; Shishodia S; Takada Y; Banerjee S; Newman RA; Bueso-Ramos CE; Price JE
    Clin Cancer Res; 2005 Oct; 11(20):7490-8. PubMed ID: 16243823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation.
    Aggarwal S; Ichikawa H; Takada Y; Sandur SK; Shishodia S; Aggarwal BB
    Mol Pharmacol; 2006 Jan; 69(1):195-206. PubMed ID: 16219905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression profiles of apoptotic genes induced by curcumin in human breast cancer and mammary epithelial cell lines.
    Ramachandran C; Rodriguez S; Ramachandran R; Raveendran Nair PK; Fonseca H; Khatib Z; Escalon E; Melnick SJ
    Anticancer Res; 2005; 25(5):3293-302. PubMed ID: 16101141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cycle arrest and apoptosis in MDA-MB-231/Her2 cells induced by curcumin.
    Sun SH; Huang HC; Huang C; Lin JK
    Eur J Pharmacol; 2012 Sep; 690(1-3):22-30. PubMed ID: 22705896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP-1 translocation, and modulation of apoptosis.
    Divya CS; Pillai MR
    Mol Carcinog; 2006 May; 45(5):320-32. PubMed ID: 16526022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin blocks RON tyrosine kinase-mediated invasion of breast carcinoma cells.
    Narasimhan M; Ammanamanchi S
    Cancer Res; 2008 Jul; 68(13):5185-92. PubMed ID: 18593918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.